Evidence map›Paper›PMID 28809799›Full record

ReviewMaterials (Basel, Switzerland)2017

Update on Monoterpenes as Antimicrobial Agents: A Particular Focus on p-Cymene.

Anna Marchese, Carla Renata Arciola, Ramona Barbieri, Ana Sanches Silva, Seyed Fazel Nabavi, Arold Jorel Tsetegho Sokeng, Morteza Izadi, Nematollah Jonaidi Jafari, Ipek Suntar, Maria Daglia and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 333 citations in OpenAlex.

  1. Green Synthesis of AgNP-Decorated MWCNTs viaMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Modulation of Antimicrobial Resistance inAntibiotics (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Anna MarcheseSezione di Microbiologia DISC-IRCCS San Martino-IST University of Genoa, 16132 Genoa, Italy. anna.marchese@unige.it.
Carla Renata ArciolaResearch Unit on Implant Infections, Rizzoli Orthopaedic Institute, via di Barbiano 1/10, 40136 Bologna, Italy. carlarenata.arciola@ior.it.
Ramona BarbieriSezione di Microbiologia DISC-IRCCS San Martino-IST University of Genoa, 16132 Genoa, Italy. ramona.barbieri@unige.it.
Ana Sanches SilvaNational Institute for Agricultural and Veterinary Research (INIAV), I.P., Vairão, 4480 Vila do Conde, Portugal. anateress@gmail.com.
Seyed Fazel NabaviApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran 19395-5487, Iran. nabavisf@gmail.com.
Arold Jorel Tsetegho SokengDepartment of Drug Sciences, Medicinal Chemistry and Pharmaceutical Technology Section, University of Pavia, 27100 Pavia, Italy. aroldjorel.tseteghosokeng@universitadipavia.it.
Morteza IzadiHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran 19395-5487, Iran. morteza_izadi@yahoo.com.
Nematollah Jonaidi JafariHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran 19395-5487, Iran. mjafari@hs.uci.edu.
Ipek SuntarDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler, Ankara 06330, Turkey. kriptogam@gmail.com.
Maria DagliaDepartment of Drug Sciences, Medicinal Chemistry and Pharmaceutical Technology Section, University of Pavia, 27100 Pavia, Italy. maria.daglia@unipv.it.
Seyed Mohammad NabaviApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran 19395-5487, Iran. nabavi208@gmail.com.
Baqiyatallah University of Medical Sciences · IROspedale Policlinico San Martino · ITUniversity of Pavia · ITGazi University · TRInstituto Nacional de Investigação Agrária e Veterinária · PTIstituto Ortopedico Rizzoli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p-Cymene [1-methyl-4-(1-methylethyl)-benzene] is a monoterpene found in over 100 plant species used for medicine and food purposes. It shows a range of biological activity including antioxidant, anti-inflammatory, antinociceptive, anxiolytic, anticancer and antimicrobial effects. This last property has been widely investigated due to the urgent need for new substances with antimicrobial properties, to be used to treat communicable diseases whose diffusion in developed countries has been facilitated by globalization and the evolution of antimicrobial resistance. This review summarizes available scientific data, as reported by the most recent studies describing the antimicrobial activity of p-cymene either alone, or as the main component of plant extracts, as well as addressing the mechanisms of action of cymenes as antimicrobial agents. While p-cymene is one of the major constituents of extracts and essential oils used in traditional medicines as antimicrobial agents, but considering the limited data on its in vivo efficacy and safety, further studies are required to reach a definitive recommendation on the use and beneficial effects of p-cymene in human healthcare and in biomedical applications as a promising candidate to functionalize biomaterials and nanomaterials.

Indexed as

antibacterialantimicrobialcymenesmonoterpenes

Identifiers

PMID28809799
PMCPMC5578313
OpenAlexW2746546304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.